Robotech Stories: Identify opportunities with surgical precision
Companies and investors alike are gaining an appreciation of the increasingly sophisticated and scalable solutions offered by robotics, particularly within distribution and manufacture. Yet, the benefits of accelerating developments within the wider robotech universe are also penetrating exciting new sectors, such as healthcare. This is not a new concept; the first robotic surgical operation on a human took place in 1985, when the Programmable Universal Machine for Assembly 200, or PUMA, performed a neurosurgical biopsy, and was rapidly adapted for orthopaedic functions
In the present, robotic surgery represents one of several disruptive technologies that originated in previous decades, such as artificial intelligence (AI), yet are increasingly becoming an essential and integrated part of our lives in recent years. Growth and uptake are being driven by accelerated development in both hardware and software capabilities, alongside increased demand for safer, more precise, and innovative medical care for a growing (and ageing) global population.
Opportunities within robotic surgery are also emerging from specialised companies such as California-based Procept BioRobotics, with its specific focus on revolutionising urology patient care. Its AQUABEAM system offers advanced, image-guided, surgical robotics which aim to reduce the invasiveness of traditional urologic surgery, and improve outcomes for patients.
These companies present just part of the growing and dynamic set of opportunities available to investors in robotech, and to those seeking to capture a suitably diverse exposure to the long-term growth potential associated with robotics.
Companies shown are for illustrative purposes only as of 30/09/2024. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities.
Disclaimer
BNP Paribas Group's acquisition of AXA Investment Managers was completed on 1 July 2025, and AXA Investment Managers is now part of BNP Paribas Group.
This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of BNP Paribas Asset Management or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.
Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, BNP Paribas Asset Management, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.
All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone.
Some of the services listed on this Website may not be available for offer to retail investors.
This Website has not been reviewed by the SFC. © 2026 BNP Paribas Asset Management. All rights reserved.